Medicilon is the first CRO to offer preclinical animal testing service for the global pharmaceutical companies in China. We provide the IND filing for the preclinical services. Medicilon is the CRO that fulfill both the Chinese and US GLP standards. Medicilon could submit the application for both US FDA and CFDA for your new drug. Since 2004, we have successfully helped our clients to submit their new drug application to US FDA and CFDA and met the requirements of the US FDA and CFDA. We have undergone several inspections and passed all of them. Medicilon will provide an efficient, cost-effective and professional service to help our clients to achieve their goals.